ClinicalTrials.Veeva

Menu

Evidence of Spreading Vasoconstriction in Human Gingiva

S

Semmelweis University

Status

Completed

Conditions

Oral Soft Tissue Conditions
Dental and Gingival Conditions
Vasoconstriction

Treatments

Drug: Epinephrine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to observe the mechanism of spreading vasoconstriction in human healthy gingiva. Epinephrine solution is applied on the attached gingiva in group "A" and on the surface of the tooth next to the ginvial sulcus in group "B". The different placement of the solution causes different effect in the microcirculation.

Full description

Spatial regulation of gingival microcirculation has not been revealed yet. Although this could be an important mechanism to protect gingiva as it is exposed to mechanical, chemical, thermal etc. irritation during whole life. It is especially important during flap surgery. Laser Speckle Contrast Imaging (LSCI) is novel non-invasive method with high spatio-temporal resolution, therefore it allows us to study remote effect of local vasoconstriction such as spreading vasoconstriction in human gingiva.

The epinephrine is a daily used vasoconstrictor material in dentistry and it will be used to trigger remote effect on gingiva. Epinephrine in 1 mg/ml concentration. Solution will be dropped on the gingiva at tooth 12 in a fabricated leakage proof well attached to 2mm above the marginal gingiva in group "A". The solution will be dropped on the surface of tooth 12 next to the sulcus into the well in case of group "B". The changes of the blood flow will be monitor at the test side with surrounding gingival area by LSCI. The control side in each case will be - appropriately to the test side - at tooth 21 with phisiologocal saline.

Enrollment

29 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • at least 5 mm keratinized gingiva at the upper front teeth
  • general health

Exclusion criteria

  • pregnancy, breast-feeding
  • any medication
  • smoking, gingivitis, caries and coronal restoration with insufficient marginal integrity

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

29 participants in 2 patient groups

Epinephrine effect throught keratinized ginigva
Experimental group
Description:
1 mg/ml epniephrine vs physiologocal saline
Treatment:
Drug: Epinephrine
Epinephrine effect throught gingival sulcular epithelium
Experimental group
Description:
1 mg/ml epniephrine vs physiologocal saline
Treatment:
Drug: Epinephrine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems